Tower Research Capital LLC (Trc) Caladrius Biosciences, Inc. Transaction History

Tower Research Capital LLC (Trc)

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.41 - $0.74 $3,832 - $6,917	9,348 Added 105.08%	18,244 $10,000
Q1 2022 May 12, 2022	BUY	$0.63 - $1.03 $4,607 - $7,532	7,313 Added 461.97%	8,896 $6,000
Q4 2021 Feb 14, 2022	BUY	$0.83 - $1.22 $1,195 - $1,756	1,440 Added 1006.99%	1,583 $1,000
Q3 2021 Nov 15, 2021	BUY	$1.15 - $1.57 $164 - $224	143 New	143 $0
Q1 2021 May 17, 2021	SELL	$1.44 - $2.89 $7,139 - $14,328	-4,958 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$1.39 - $1.87 $11,528 - $15,509	-8,294 Reduced 62.59%	4,958 $7,000
Q3 2020 Nov 16, 2020	BUY	$1.6 - $3.0 $8,150 - $15,282	5,094 Added 62.44%	13,252 $24,000
Q2 2020 Aug 13, 2020	BUY	$1.66 - $2.38 $13,542 - $19,416	8,158 New	8,158 $15,000
Q3 2019 Nov 05, 2019	SELL	$2.22 - $2.99 $7,778 - $10,476	-3,504 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$2.25 - $3.6 $7,884 - $12,614	3,504 New	3,504 $8,000

Ticker CLBS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,583,200
Market Cap $25.8M
Description
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical li...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.